Description

About Heparin

Heparin, a disaccharide anticoagulant or blood thinner, prevents the formation of blood clots. It is produced in the body by basophils and mast cells. It is stored within mast cells and secreted at the injury site. Though it has no effect on already formed clots, it enables the body's natural clot lysis mechanisms to dissolve clots. It can also be taken from outside as a drug. Heparin can be derived from natural sources such as pig intestine and bovine lungs.
Heparin is divided into two types based on the fractionation process. Both types have medical use, with the selection done based on preference for a particular condition.

UFH: It is directly obtained from natural sources, without undergoing any fractionation.
LMWH: It is derived by depolymerizing UFH. The pharmacodynamics properties of LMWH are more predictable when compared to UFH.
Apart from these, another category of molecules, ULMWH are available. They are structurally related to LMWHs, but differ in the composition of monosaccharides and oligosaccharides. Therefore, they have different average molecular weights from LMWH.

Technavios analysts forecast the Global Heparin Market to grow at a CAGR of 4.74% during the period 2016-2020.

Covered in this report

The report covers the present scenario and the growth prospects of the global heparin market for 2016-2020. To calculate the market size, the report considers revenue generated from the sales of branded and generics used to treat disorders.

The market is divided into the following segments based on geography:

Americas
APAC
EMEA

Technavio's report, Global Heparin Market 2016-2020, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market.

Download Detail Report With Complete TOC at: http://www.marketresearchreports.biz/sample/sample/668428

Key vendors

GlaxoSmithKline plc (GSK)
Leo Pharma A/S
Pfizer Inc.
Sanofi

Other prominent vendors

Alchemi
Baxter
BMS
Boehringer Ingelheim
Celgene
Cosmo Pharmaceuticals
Dr.Reddy's Laboratories
Eisai
Fresenius
GSK
Hospira
Laboratorios Rovi Pharmaceuticals
Lee's Pharmaceutical
Momenta Pharmaceuticals
Mylan
Novartis
Ockham Biotech
Perospher
PolyMedix
Portola Pharmaceutical
ProStrakan Group
Sagent Pharmaceticals
Sigma Tau Pharmaceuticals
UCB
Urigen Pharmaceuticals

Market driver

Growing prevalence of diseases
For a full, detailed list, view our report

Market challenge

Extensive use of generic products due to patent expirations
For a full, detailed list, view our report

Market trend

Expected exploitation of new therapeutic use
For a full, detailed list, view our report

Key questions answered in this report

What will the market size be in 2020 and what will the growth rate be?
What are the key market trends?
What is driving this market?
What are the challenges to market growth?
Who are the key vendors in this market space?
What are the market opportunities and threats faced by the key vendors?
What are the strengths and weaknesses of the key vendors?

Browse More PressRelease:
http://www.marketresearchreports.biz/pressreleases

About us

MarketResearchReports.biz is the most comprehensive collection of market research reports.
MarketResearchReports.Biz services are specially designed to save time and money for our clients.
We are a one stop solution for all your research needs, our main offerings are syndicated research
reports, custom research, subscription access and consulting services. We serve all sizes and types
of companies spanning across various industries.

Contact

Mr. Nachiket
90 Sate Street, Suite 700
Albany, NY 12207
Tel: +1-518-621-2074
Website: http://www.marketresearchreports.biz/
E: [email protected]